Genscript Biotech tumbles 12% in Hong Kong trading

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Genscript Biotech (1548.HK) tumbled more than 12% in Hong Kong trading, last at HK$29.62.

The stock is down 16.22% over the past five sessions, up 103.61% over the past six months and up 136.23% year to date. It sits 40.11% below its 52-week high of HK$49.46.

The Hang Seng Index is up 4.87% over the past five sessions and down 4.69% year to date.

The life sciences tools and services industry index fell 4.2% over the same period.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.